ENDRA Life Sciences Inc. (NDRA) |
|
1.25 -0.04 (-3.1%)
|
02-20 15:59 |
|
Open: |
1.36 |
Pre. Close: |
1.29 |
|
High:
|
1.36 |
Low:
|
1.24 |
|
Volume:
|
80,782 |
Market Cap:
|
11M |
|
|
|
|
ENDRA Life Sciences Inc develops diagnostics and research products to improve the specificity of clinical ultrasound. Its products allow researchers and clinicians to generate images to identify and cure diseases. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.364 - 1.371 |
1.371 - 1.378 |
|
Low:
|
1.218 - 1.228 |
1.228 - 1.236 |
|
Close:
|
1.235 - 1.25 |
1.25 - 1.262 |
|
Technical analysis |
as of: 2020-02-20 4:42:11 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 2.06 One year: 2.44 |
| Support: |
Support1: 1.23 Support2: 1.03 |
| Resistance: |
Resistance1: 1.76 Resistance2: 2.09 |
| Pivot: |
1.40  |
| Moving Average: |
MA(5): 1.31 MA(20): 1.46
MA(100): 1.25  MA(250): 1.47 |
| MACD: |
MACD(12,26): -0.07 Signal(9): -0.04 |
| Stochastic oscillator: |
%K(14,3): 8.44 %D(3): 12.35 |
| RSI: |
RSI(14): 37.84 |
| 52-week: |
High: 3.49 Low: 0.62 Change(%): -30.2 |
| Average Vol(K): |
3-Month: 14691 10-Days: 6035 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.NDRA has closed above bottom band by 3.9%. Bollinger Bands are 42.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to NDRA's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
2020-01-15
ENDRA Life Sciences Renews GE Healthcare Collaboration Agreement
Supports Commercialization of TAEUS Liver Product Targeting NAFLD-NASH ANN ARBOR, MI / ACCESSWIRE / January 15, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic …
2019-11-22
The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 21.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Amgen, Inc. (NASDAQ: AMGN ) (raised full-year guidance following completion of Otezla purchase from Celgene) Antares Pharma Inc (NASDAQ: ATRS ) Arvinas Inc (NASDAQ: ARVN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) BIO-TECHNE Corp (NASDAQ: TECH ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Cue Biopharma Inc (NASDAQ: CUE ) Epizyme Inc (NASDAQ: EPZM ) Kamada Ltd. (NASDAQ: KMDA ) Kodiak Sciences Inc (NASDAQ: KOD ) Molecular Templates Inc (NASDAQ: MTEM ) Recro Pharma Inc (NASDAQ: REPH ) (completed spin-off of Baudax Bio in a bid to a become a pure play CDMO) Down In The Dumps (Biotech stocks that hit 52-week lows on Nov. 21.) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) (received European approval for its Rhokiinsa 0.02% for the reduction of elevated intraocular pressure) Affimed NV (NASDAQ: AFMD ) Anixa Biosciences Inc (NASDAQ: ANIX ) CareDx Inc (NASDAQ: CDNA ) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) ENDRA Life Sciences Inc (NASDAQ: NDRA ) Genprex Inc (NASDAQ: GNPX ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Interpace Biosciences Inc (NASDAQ: IDXG ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) (priced its previously announced common stock offering) Iterum Therapeutics PLC (NASDAQ: ITRM ) Jaguar Health Inc (NASDAQ: JAGX ) MacroGenics Inc (NASDAQ: MGNX ) Merrimack Pharmaceuticals Inc (NASDAQ: MACK ) Neon Therapeutics Inc (NASDAQ: NTGN ) (announced a changed focus and the elimination of 24% of workforce) Novavax, Inc. (NASDAQ: NVAX ) Nuvectra Corp (NASDAQ: NVTR ) Onconova Therapeutics …
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
